(FY)Dec 30, 2023 | (FY)Dec 30, 2022 | |
---|---|---|
Operating cash flow (direct method) | ||
Cash income from operating activities | 660.91%837K | 110K |
Other cash income from operating activities | 660.91%837K | --110K |
Cash paid | 4.60%-8.24M | -8.63M |
Payments to suppliers for goods and services | 4.60%-8.24M | ---8.63M |
Direct interest received | 1,438.76%1.99M | --129K |
Operating cash flow | 35.50%-5.41M | ---8.39M |
Investing cash flow | ||
Cash flow from continuing investing activities | -380.01%-31.92M | -6.65M |
Net PPE purchase and sale | -141.67%-87K | ---36K |
Net other investing changes | -381.31%-31.83M | ---6.61M |
Cash from discontinued investing activities | ||
Investing cash flow | -380.01%-31.92M | ---6.65M |
Financing cash flow | ||
Cash flow from continuing financing activities | 86.4M | |
Net issuance payments of debt | ---- | ---9.95M |
Net common stock issuance | ---- | --96.65M |
Interest paid (cash flow from financing activities) | ---- | ---308K |
Cash from discontinued financing activities | ||
Financing cash flow | ---- | --86.4M |
Net cash flow | ||
Beginning cash position | 307,873.91%70.83M | --23K |
Current changes in cash | -152.32%-37.33M | --71.36M |
Effect of exchange rate changes | 110.46%57K | ---545K |
End cash Position | -52.62%33.56M | --70.83M |
Free cash from | 34.74%-5.5M | ---8.43M |
Accounting Standards | US-GAAP | US-GAAP |
No Data